Palmitoylated tetrapeptide studied in cosmetic preparations for anti-inflammatory / anti-glycation claims.
Palmitoyl-Gly-Gln-Pro-Arg. Part of common anti-aging peptide blends. Proposed reduction of cytokine-driven skin inflammation.
Evidence summary in progress. See the citations section below for the underlying research papers.
No FDA label or editorial side-effect profile is on file for this compound yet. See the clinical trials and citations sections for study-reported safety data.
No documented drug interactions on file.
Not FDA approved. Cosmetic ingredient.
Not available via 503A/503B compounding pharmacies.
Regulatory data last verified 4/19/2026
No citations indexed yet.